Literature DB >> 1431165

Chicken antibodies: a tool to avoid interference by complement activation in ELISA.

A Larsson1, P E Wejåker, P O Forsberg, T Lindahl.   

Abstract

MicroELISA plates coated with mammalian IgG will activate the human complement system. It has been shown that this activation of the complement system may interfere in solid-phase immunometric assays, and that there is a difference between IgG from different species and between different IgG subclasses in their ability to activate the human complement system. We have studied the ability of mammalian IgG and avian IgG to activate the human complement system. We show that chicken IgG do not activate the human complement system, and chicken IgG can thus be used in solid-phase immunometric assays to reduce interference by complement activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1431165     DOI: 10.1016/0022-1759(92)90013-j

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Maternally transferred antibodies from DNA-immunized avians protect offspring against hepadnavirus infection.

Authors:  C Rollier; C Charollois; C Jamard; C Trepo; L Cova
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

2.  How well can a T-cell epitope replace its parent carrier protein? A dose-response study.

Authors:  James S Cavenaugh; Hsu-Kun Wang; Cory Hansen; Richard S Smith; James N Herron
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200

3.  Production of IgY polyclonal antibody against diphtheria toxin and evaluation of its neutralization effect by Vero cell assay.

Authors:  Morteza Rezaeifard; Roya Solhi; Mohammad Mohammadi; Ebrahim Abbasi; Mahdi Aminian
Journal:  BMC Biotechnol       Date:  2021-05-12       Impact factor: 2.563

4.  Identification and profiling of circulating antigens by screening with the sera from schistosomiasis japonica patients.

Authors:  Yan Lu; Bin Xu; Chuan Ju; Xiaojin Mo; Shenbo Chen; Zheng Feng; Xiaoning Wang; Wei Hu
Journal:  Parasit Vectors       Date:  2012-06-11       Impact factor: 3.876

5.  IL-8 and cathepsin B as melanoma serum biomarkers.

Authors:  Hongtao Zhang; Ting Fu; Suzanne McGettigan; Suresh Kumar; Shujing Liu; David Speicher; Lynn Schuchter; Xiaowei Xu
Journal:  Int J Mol Sci       Date:  2011-02-25       Impact factor: 5.923

6.  Antiviral Biologic Produced in DNA Vaccine/Goose Platform Protects Hamsters Against Hantavirus Pulmonary Syndrome When Administered Post-exposure.

Authors:  Nicole Haese; Rebecca L Brocato; Thomas Henderson; Matthew L Nilles; Steve A Kwilas; Matthew D Josleyn; Christopher D Hammerbeck; James Schiltz; Michael Royals; John Ballantyne; Jay W Hooper; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

7.  Dengue virus specific IgY provides protection following lethal dengue virus challenge and is neutralizing in the absence of inducing antibody dependent enhancement.

Authors:  Ashley L Fink; Katherine L Williams; Eva Harris; Travis D Alvine; Thomas Henderson; James Schiltz; Matthew L Nilles; David S Bradley
Journal:  PLoS Negl Trop Dis       Date:  2017-07-07

Review 8.  Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review.

Authors:  E P V Pereira; M F van Tilburg; E O P T Florean; M I F Guedes
Journal:  Int Immunopharmacol       Date:  2019-05-22       Impact factor: 4.932

9.  Egg yolk immunoglobulin (IgY) targeting SARS-CoV-2 S1 as potential virus entry blocker.

Authors:  Lirong Bao; Cheng Zhang; Jinglu Lyu; Ping Yi; Xin Shen; Boyu Tang; Hang Zhao; Biao Ren; Yu Kuang; Linlin Zhou; Yan Li
Journal:  J Appl Microbiol       Date:  2021-11-03       Impact factor: 4.059

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.